Zepto: More Than a Capsulotomy Device

(Mynosys Cellular Devices, Fremont, California) entered the U.S. market in June 2017, and since then, surgeons have found the automated capsulotomy device provides numerous clinical benefits. By shortening surgery time, providing consistent, circular capsulotomies, preserving visual axis information during surgery, and reducing risks of some complications, the Zepto device makes complex cases routine and can even extend a seasoned surgeon’s career, according to physicians who use it regularly.

For more information: https://www.eyeworld.org/

Related Articles

Share on facebook
Share on whatsapp
Share on email